HUMA · Humacyte Inc. Common Stock
View on chartInsiders & Stakes
| Ayabudge LLC 10% Owner | ▼ Sell | Open Market | 8,191,140 Shares held | 8/21/2023 | View profile |
| Shamik J. Parikh Chief Medical Officer | ▼ Sell | Open Market | 272,713 Shares held | 5/18/2026 | View profile |
| Dale A. Sander CFO and Chief Corp. Deve. Off. | ▼ Sell | Open Market | 267,213 Shares held | 5/18/2026 | View profile |
| Binder Gordon M Director | ▲ Buy | Open Market | 160,000 Shares held | 5/15/2024 | View profile |
| Kathleen Sebelius Director | ▲ Buy | Open Market | 148,025 Shares held | 5/19/2026 | View profile |
| Tente William Edward Chief Regulatory Officer | ▲ Buy | Grant | 52,519 Shares held | 8/26/2021 | View profile |
| Jones Keith Anthony | ▲ Buy | Open Market | 50,000 Shares held | 9/14/2026 | View profile |
| Michael T. Constantino Director | ▲ Buy | Open Market | 43,950 Shares held | 5/18/2026 | View profile |
| William John Scheessele Chief Commercial Officer | ▲ Buy | Open Market | 22,018 Shares held | 4/14/2025 | View profile |
| Charles Bruce Green Director | ▲ Buy | Open Market | 8,400 Shares held | 4/8/2025 | View profile |
| Lawson Jeffrey Harold Chief Surgical Officer | ▲ Buy | Grant | 7,877 Shares held | 8/26/2021 | View profile |
| Wallace Max N. Director | ▲ Buy | Open Market | 3,990 Shares held | 5/20/2024 | View profile |
| Brady W. Dougan Director | ▼ Sell | Open Market | 0 Shares held | 8/20/2025 | View profile |
| Laura E. Niklason President, CEO and Director | ▼ Sell | Open Market | 0 Shares held | 8/20/2025 | View profile |
| Prichard Heather Ledbetter Chief Operating Officer | ▼ Sell | Open Market | 0 Shares held | 5/31/2024 | View profile |
Transaction History
| Jones Keith Anthony | ▲ Buy | Open Market | 10,000 | $6K | 9/14/2026 |
| Jones Keith Anthony | ▲ Buy | Open Market | 10,000 | $7K | 8/20/2026 |
| Jones Keith Anthony | ▲ Buy | Open Market | 30,000 | $18K | 8/17/2026 |
| Kathleen Sebelius | ▲ Buy | Open Market | 56,818 | $50K | 5/19/2026 |
| Shamik J. Parikh | ▼ Sell | Open Market | 45,887 | $41K | 5/18/2026 |
| Michael T. Constantino | ▲ Buy | Open Market | 11,000 | $10K | 5/18/2026 |
| Dale A. Sander | ▼ Sell | Open Market | 45,887 | $41K | 5/18/2026 |
| Dale A. Sander | ▲ Buy | Grant | 311,100 | $0 | 11/16/2025 |
| Shamik J. Parikh | ▲ Buy | Grant | 311,100 | $0 | 11/16/2025 |
| Brady W. Dougan | ▼ Sell | Open Market | 591,685 | $935K | 8/20/2025 |
| Laura E. Niklason | ▼ Sell | Open Market | 591,685 | $935K | 8/20/2025 |
| Brady W. Dougan | ▼ Sell | Open Market | 1,100,000 | $1.8M | 8/19/2025 |
| Laura E. Niklason | ▼ Sell | Open Market | 1,100,000 | $1.8M | 8/19/2025 |
| Brady W. Dougan | ▼ Sell | Open Market | 549,360 | $1.0M | 8/18/2025 |
| Laura E. Niklason | ▼ Sell | Open Market | 549,360 | $1.0M | 8/18/2025 |
| William John Scheessele | ▲ Buy | Open Market | 6,493 | $10K | 4/14/2025 |
| Dale A. Sander | ▲ Buy | Open Market | 20,000 | $31K | 4/10/2025 |
| Shamik J. Parikh | ▲ Buy | Open Market | 7,500 | $12K | 4/10/2025 |
| Kathleen Sebelius | ▲ Buy | Open Market | 50,000 | $66K | 4/8/2025 |
| Charles Bruce Green | ▲ Buy | Open Market | 6,000 | $8K | 4/8/2025 |
| Michael T. Constantino | ▲ Buy | Open Market | 16,000 | $20K | 4/7/2025 |
| Michael T. Constantino | ▲ Buy | Open Market | 4,600 | $20K | 12/4/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 261,369 | $1.2M | 11/20/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 261,369 | $1.2M | 11/20/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 427,459 | $1.9M | 11/19/2024 |
| Laura E. Niklason | ▲ Buy | Open Market | 1,797 | $8K | 11/19/2024 |
| Brady W. Dougan | ▲ Buy | Open Market | 1,797 | $8K | 11/19/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 427,459 | $1.9M | 11/19/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 811,172 | $3.6M | 11/18/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 811,172 | $3.6M | 11/18/2024 |
| Charles Bruce Green | ▲ Buy | Option Exercise | 1,200 | $5K | 9/13/2024 |
| Kathleen Sebelius | ▲ Buy | Option Exercise | 4,521 | $20K | 9/10/2024 |
| Kathleen Sebelius | ▼ Sell | Open Market | 3,634 | $20K | 9/10/2024 |
| Kathleen Sebelius | ▲ Buy | Option Exercise | 2,479 | $8K | 9/10/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 288,674 | $1.5M | 9/10/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 288,674 | $1.5M | 9/10/2024 |
| Kathleen Sebelius | ▼ Sell | Open Market | 1,548 | $8K | 9/10/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 157,704 | $855K | 9/9/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 157,704 | $855K | 9/9/2024 |
| Laura E. Niklason | ▲ Buy | Open Market | 1,222 | $8K | 8/29/2024 |
| Brady W. Dougan | ▲ Buy | Open Market | 1,222 | $8K | 8/29/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 352,112 | $2.2M | 8/29/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 352,112 | $2.2M | 8/29/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 277,090 | $1.8M | 8/28/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 277,090 | $1.8M | 8/28/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 252,676 | $1.7M | 8/27/2024 |
| Dale A. Sander | ▼ Sell | Open Market | 39,389 | $263K | 8/27/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 252,676 | $1.7M | 8/27/2024 |
| Dale A. Sander | ▲ Buy | Option Exercise | 39,389 | $101K | 8/27/2024 |
| Michael T. Constantino | ▲ Buy | Open Market | 3,100 | $19K | 8/15/2024 |
| Kathleen Sebelius | ▲ Buy | Option Exercise | 39,389 | $101K | 6/14/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 271,518 | $2.0M | 6/12/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 271,518 | $2.0M | 6/12/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 282,000 | $2.0M | 6/11/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 76,630 | $538K | 6/11/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 282,000 | $2.0M | 6/11/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 76,630 | $538K | 6/11/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 1,852 | $13K | 6/4/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 1,852 | $13K | 6/4/2024 |
| Laura E. Niklason | ▲ Buy | Open Market | 2,362 | $15K | 6/4/2024 |
| Brady W. Dougan | ▲ Buy | Open Market | 2,362 | $15K | 6/4/2024 |
| Brady W. Dougan | ▲ Buy | Open Market | 2,050 | $15K | 6/3/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 190,214 | $1.4M | 6/3/2024 |
| Laura E. Niklason | ▲ Buy | Open Market | 2,050 | $15K | 6/3/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 190,214 | $1.4M | 6/3/2024 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 2,625 | $25K | 5/31/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 716,573 | $5.6M | 5/31/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 716,573 | $5.6M | 5/31/2024 |
| Brady W. Dougan | ▼ Sell | Open Market | 93,213 | $832K | 5/31/2024 |
| Laura E. Niklason | ▼ Sell | Open Market | 93,213 | $832K | 5/31/2024 |
| Prichard Heather Ledbetter | ▲ Buy | Option Exercise | 78,779 | $202K | 5/30/2024 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 78,779 | $659K | 5/30/2024 |
| Prichard Heather Ledbetter | ▲ Buy | Option Exercise | 48,166 | $148K | 5/30/2024 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 48,166 | $401K | 5/30/2024 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 61,941 | $478K | 5/30/2024 |
| Wallace Max N. | ▲ Buy | Open Market | 3,990 | $25K | 5/20/2024 |
| Charles Bruce Green | ▲ Buy | Option Exercise | 600 | $2K | 5/20/2024 |
| Wallace Max N. | ▲ Buy | Open Market | 4,015 | $25K | 5/20/2024 |
| Charles Bruce Green | ▲ Buy | Option Exercise | 600 | $2K | 5/17/2024 |
| Binder Gordon M | ▲ Buy | Open Market | 50,000 | $329K | 5/15/2024 |
| Binder Gordon M | ▲ Buy | Open Market | 50,000 | $339K | 5/15/2024 |
| Wallace Max N. | ▲ Buy | Option Exercise | 6,564 | $8K | 11/21/2023 |
| Brady W. Dougan | ▲ Buy | Option Exercise | 114,420 | $136K | 10/10/2023 |
| Laura E. Niklason | ▲ Buy | Option Exercise | 114,420 | $136K | 10/10/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 2,000,000 | $5.6M | 9/14/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 2,000,000 | $5.6M | 9/14/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 602,443 | $2.0M | 8/21/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 602,443 | $2.0M | 8/21/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 602,443 | $2.0M | 8/21/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 626,979 | $2.2M | 8/18/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 626,979 | $2.2M | 8/18/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 626,979 | $2.2M | 8/18/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 570,174 | $2.1M | 8/17/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 570,174 | $2.1M | 8/17/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 570,174 | $2.1M | 8/17/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 500,000 | $1.6M | 6/15/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 500,000 | $1.6M | 6/15/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 500,000 | $1.6M | 6/15/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 4,875,000 | $12.7M | 6/13/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 4,875,000 | $12.7M | 6/13/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 4,875,000 | $12.7M | 6/13/2023 |
| Prichard Heather Ledbetter | ▲ Buy | Option Exercise | 64,990 | $77K | 5/25/2023 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 9,613 | $37K | 5/25/2023 |
| Ayabudge LLC | ▼ Sell | Open Market | 2,625,000 | $7.2M | 5/25/2023 |
| Brady W. Dougan | ▼ Sell | Open Market | 2,625,000 | $7.2M | 5/25/2023 |
| Laura E. Niklason | ▼ Sell | Open Market | 2,625,000 | $7.2M | 5/25/2023 |
| Prichard Heather Ledbetter | ▼ Sell | Open Market | 13,789 | $57K | 5/24/2023 |
| Prichard Heather Ledbetter | ▲ Buy | Option Exercise | 13,789 | $16K | 5/24/2023 |
| Michael T. Constantino | ▲ Buy | Open Market | 4,750 | $20K | 5/18/2023 |
| Brady W. Dougan | ▲ Buy | Option Exercise | 100,000 | $119K | 3/1/2023 |
| Laura E. Niklason | ▲ Buy | Option Exercise | 100,000 | $119K | 3/1/2023 |
| Dale A. Sander | ▲ Buy | Open Market | 20,000 | $52K | 12/16/2022 |
| Laura E. Niklason | ▼ Sell | Open Market | 239,538 | $606K | 12/16/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 239,538 | $606K | 12/16/2022 |
| Ayabudge LLC | ▼ Sell | Open Market | 239,538 | $606K | 12/16/2022 |
| Laura E. Niklason | ▲ Buy | Open Market | 10,000 | $25K | 12/15/2022 |
| Brady W. Dougan | ▲ Buy | Open Market | 10,000 | $25K | 12/15/2022 |
| Laura E. Niklason | ▼ Sell | Open Market | 93,426 | $246K | 12/15/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 93,426 | $246K | 12/15/2022 |
| Ayabudge LLC | ▼ Sell | Open Market | 93,426 | $246K | 12/15/2022 |
| Laura E. Niklason | ▼ Sell | Open Market | 276,304 | $763K | 12/14/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 276,304 | $763K | 12/14/2022 |
| Ayabudge LLC | ▼ Sell | Open Market | 276,304 | $763K | 12/14/2022 |
| Dale A. Sander | ▼ Sell | Other | 600 | $0 | 12/13/2022 |
| William John Scheessele | ▲ Buy | Open Market | 5,000 | $15K | 12/13/2022 |
| Laura E. Niklason | ▼ Sell | Open Market | 330,000 | $937K | 12/13/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 330,000 | $937K | 12/13/2022 |
| Ayabudge LLC | ▼ Sell | Open Market | 330,000 | $937K | 12/13/2022 |
| Prichard Heather Ledbetter | ▲ Buy | Option Exercise | 6,564 | $8K | 12/12/2022 |
| Laura E. Niklason | ▼ Sell | Open Market | 1,522,500 | $6.1M | 9/15/2022 |
| Laura E. Niklason | ▲ Buy | Open Market | 2,000 | $8K | 9/15/2022 |
| Brady W. Dougan | ▲ Buy | Open Market | 2,000 | $8K | 9/15/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 1,522,500 | $6.1M | 9/15/2022 |
| Ayabudge LLC | ▼ Sell | Open Market | 1,522,500 | $6.1M | 9/15/2022 |
| Binder Gordon M | ▲ Buy | Open Market | 61,841 | $272K | 9/2/2022 |
| Binder Gordon M | ▲ Buy | Open Market | 48,159 | $193K | 9/1/2022 |
| William John Scheessele | ▲ Buy | Open Market | 10,525 | $50K | 5/24/2022 |
| Brady W. Dougan | ▲ Buy | Open Market | 10,000 | $48K | 5/23/2022 |
| Laura E. Niklason | ▲ Buy | Open Market | 10,000 | $48K | 5/23/2022 |
| Michael T. Constantino | ▲ Buy | Open Market | 2,000 | $10K | 5/23/2022 |
| Dale A. Sander | ▲ Buy | Open Market | 2,000 | $9K | 5/17/2022 |
| Brady W. Dougan | ▼ Sell | Open Market | 75,000 | $675K | 12/16/2021 |
| Laura E. Niklason | ▼ Sell | Open Market | 75,000 | $675K | 12/16/2021 |
| Laura E. Niklason | ▼ Sell | Open Market | 125,000 | $1.1M | 12/15/2021 |
| Brady W. Dougan | ▼ Sell | Open Market | 125,000 | $1.1M | 12/15/2021 |
| Brady W. Dougan | ▼ Sell | Open Market | 23,694 | $232K | 12/14/2021 |
| Laura E. Niklason | ▼ Sell | Open Market | 23,694 | $232K | 12/14/2021 |
| Laura E. Niklason | ▼ Sell | Open Market | 76,306 | $712K | 12/14/2021 |
| Brady W. Dougan | ▼ Sell | Open Market | 76,306 | $712K | 12/14/2021 |
| Michael T. Constantino | ▲ Buy | Open Market | 2,300 | $25K | 11/22/2021 |
| Michael T. Constantino | ▲ Buy | Open Market | 200 | $2K | 11/22/2021 |
| Laura E. Niklason | ▲ Buy | Open Market | 1,522,500 | $15.2M | 8/26/2021 |
| Ayabudge LLC | ▲ Buy | Grant | 18,930,004 | — | 8/26/2021 |
| Ayabudge LLC | ▲ Buy | Open Market | 1,522,500 | $15.2M | 8/26/2021 |
| Laura E. Niklason | ▲ Buy | Grant | 1,148,240 | — | 8/26/2021 |
| Prichard Heather Ledbetter | ▲ Buy | Grant | 2,625 | — | 8/26/2021 |
| Tente William Edward | ▲ Buy | Grant | 52,519 | — | 8/26/2021 |
| Lawson Jeffrey Harold | ▲ Buy | Grant | 7,877 | — | 8/26/2021 |
| Wallace Max N. | ▲ Buy | Grant | 49,986 | — | 8/26/2021 |
| Laura E. Niklason | ▲ Buy | Grant | 18,930,004 | — | 8/26/2021 |
| Brady W. Dougan | ▲ Buy | Grant | 1,148,240 | — | 8/26/2021 |
| Brady W. Dougan | ▲ Buy | Grant | 18,930,004 | — | 8/26/2021 |
| Brady W. Dougan | ▲ Buy | Open Market | 1,522,500 | $15.2M | 8/26/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Humacyte Adds Scott Coward and Paul Kuznik to Board
Humacyte added Scott Coward and Paul Kuznik to its board, expanding expertise in regulatory and clinical areas. The move comes as the stock fell 4% in a broader market rally, reflecting short‑term price pressure rather than a change in fundamentals. The new directors bring experience that could support the company’s tissue engineering pipeline, but the current price remains below the 52‑week low.
Humacyte Adds Scott Coward and Paul Kuznik to Board. Humacyte added Scott Coward and Paul Kuznik to its board, expanding expertise in regulatory and clinical areas. The move comes as the stock fell 4% in a broader market rally, reflecting short‑term price pressure rather than a change in fundamentals. The new directors bring experience that could support the company’s tissue engineering pipeline, but the current price remains below the 52‑week low.